hydroxy(triphenyl)-λ5-phosphane

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: hydroxy(triphenyl)-λ5-phosphane
• 化学式: C₁₈H₁₇OP
• 分子量: 280.3
• InChiKey: JCRTYCUNXFKTAZ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  20
• 可旋转键数：
  3
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  20.2
• 氢给体数：
  1
• 氢受体数：
  1

文献信息

• [EN] CATALYST COMPLEXES WITH CARBENE LIGAND AND METHOD FOR MAKING SAME AND USE IN METATHESIS REACTION<br/>[FR] COMPLEXES DE CATALYSEURS AVEC UN LIGAND CARBÈNE, LEUR PROCÉDÉ DE FABRICATION ET LEUR UTILISATION DANS UNE RÉACTION DE MÉTATHÈSE
  申请人：GUANG MING INNOVATION COMPANY WUHAN

  公开号：WO2014108071A1

  公开（公告）日：2014-07-17

  This invention relates to catalyst compounds and the synthesis and applications useful in olefin metathesis reactions. The catalyst compounds of the invention are represented by the formula (I): wherein M is a Group 8 metal; X1 and X2 are anionic ligands; L1 and L2 are neutral two electron donor ligands. The present invention also relates to an easy applicable catalyst synthesis and the application in different olefin metathesis processes, e.g. Reaction Injection Molding (RIM), process to make α-olefins from fatty acid ester, e.g. methyl oleate.

  这项发明涉及催化剂化合物，以及在烯烃转化反应中有用的合成和应用。该发明的催化剂化合物由式(I)表示：其中M是8族金属；X1和X2是阴离子配体；L1和L2是中性的双电子给体配体。本发明还涉及一种易于应用的催化剂合成方法，以及在不同烯烃转化过程中的应用，例如反应注射成型（RIM）过程，用于从脂肪酸酯制备α-烯烃，例如甲基油酸甲酯。
• [EN] GROUP 8 TRANSITION METAL CATALYSTS AND METHOD FOR MAKING SAME AND PROCESS FOR USE OF SAME IN METATHESIS REACTION<br/>[FR] CATALYSEURS À BASE DE MÉTAUX DE TRANSITION DU GROUPE 8 AINSI QUE LEURS PROCÉDÉS DE FABRICATION ET LEURS PROCÉDÉS D'UTILISATION DANS LA RÉACTION DE MÉTATHÈSE
  申请人：GUANG MING INNOVATION COMPANY WUHAN

  公开号：WO2016000242A1

  公开（公告）日：2016-01-07

  Metal catalyst compounds are disclosed. The catalyst compound are represented by the formula (I-II and VII): wherein M is a Group 8 metal; X is an anionic ligand; L is a neutral two electron donor ligand; K 2(A-E) is a ditopic or multitopic ligand. Also disclosed is an easy applicable catalyst synthesis and the application in different olefin metathesis processes, e.g. Reaction Injection Molding (RIM), rotational molding, vacuum infusion, vacuum forming, process for conversion of fatty acids and fatty acid esters or mixtures thereof, in –olefins, dicarboxylic acids or dicarboxylic esters, etc.

  金属催化剂化合物已被披露。该催化剂化合物由以下式(I-II和VII)表示：其中M是8族金属；X是阴离子配体；L是中性的双电子给体配体；K 2(A-E)是二元或多元配体。还披露了一种易于应用的催化剂合成方法，以及在不同的烯烃转化反应中的应用，例如反应注塑成型（RIM）、旋转成型、真空浸渍、真空成型、脂肪酸和脂肪酸酯或其混合物转化过程中的应用，以及-烯烃、二羧酸或二羧酸酯等。
• SUBSTITUTED TRIAZOLO-PYRIMIDINE COMPOUNDS FOR MODULATING CELL PROLIFERATION, DIFFERENTIATION AND SURVIVAL
  申请人：STATegics, Inc.

  公开号：US20140142122A1

  公开（公告）日：2014-05-22

  Disclosed herein are erythropoietin-mimetic compounds of Formula I, which modulate the survival, function, or differentiation of, for example, kidney cells, neurons, erythroid cells, or other erythropoietin-responsive cells. The present invention also relates to compounds and methods that preferentially modulate cells expressing the tissue-protective erythropoietin receptor. The compounds of the invention are useful in preventing and treating diseases, such as anemia, organ injury, and diseases of the central nervous system, and as an adjunct to cellular treatments, such as stem cell therapies.

  本公开涉及的是式I的类似促红细胞生成素化合物，其调节肾脏细胞、神经元、红细胞或其他促红细胞生成素反应细胞的存活、功能或分化。本发明还涉及优先调节表达组织保护性促红细胞生成素受体的细胞的化合物和方法。本发明的化合物在预防和治疗贫血、器官损伤、中枢神经系统疾病等疾病方面有用，并可作为干细胞治疗等细胞治疗的辅助手段。
• Process for producing carbonyl compound
  申请人：Mizushima Eiichiro

  公开号：US20050143597A1

  公开（公告）日：2005-06-30

  The present invention relates to a process which comprises efficiently proceeding a hydration reaction of an alkyne in aspects of turnover numbers of a catalyst, yield and speed to thereby industrially and advantageously produce the corresponding carbonyl compound. The present invention provides a process for producing a carbonyl compound, which comprises reacting an alkyne compound with water in the presence of a gold catalyst which is an organogold complex compound and acid in an organic solvent.

  本发明涉及一种工艺，其包括高效地进行炔烃的水合反应，以在催化剂的周转次数、产率和速度方面从而在工业上和有利地生产相应的羰基化合物。本发明提供了一种生产羰基化合物的工艺，其中在有机溶剂中，在存在金催化剂（一种有机金配合物）和酸的情况下，将炔烃化合物与水反应。
• [EN] CYSTEINE PROTEASE INHIBITORS<br/>[FR] INHIBITEURS DE CYSTEINE PROTEASE
  申请人：MEDIVIR AB

  公开号：WO2005066180A1

  公开（公告）日：2005-07-21

  A compound of the formula (II) wherein one of R1 and R2 is halo and the other is H or halo; R3 is C1-C4 straight or branched chain, optionally fluorinated, alkyl; R4 is H; or R3 together with R4 and the adjoining backbone carbon defines: a spiro-C5-C7 cycloalkyl, optionally substituted with 1 to 3 substituents selected from halo, hydroxyl, C1-C4 alkyl or C1-C4 haloalkyl; or optionally bridged with a methylene group; or a C4-C6 saturated heterocycle having a hetero atom selected from O, NRa, S, S(=O)2 ; where Ra is H, C1-C4 alkyl or CH3C(=O); R5 is independently selected from H or methyl; E is -C(=O)-, -S(=O)m-, -NR5S(=O)m-, -NR5C(=O)-, -OC(=O)-, R6 is a stable, optionally substituted, monocyclic or bicyclic, carbocycle or hetorocycle; m is independently 0,1 or 2; are inhibitors of cathepsin K and useful in the treatment or prophylaxis of osteoporosis.

  一个公式为(II)的化合物，其中R1和R2中的一个是卤素，另一个是H或卤素；R3是C1-C4直链或支链，可选择氟代的烷基；R4是H；或者R3与R4和相邻的骨架碳一起定义：一个螺环C5-C7环烷基，可选地用1至3个卤素、羟基、C1-C4烷基或C1-C4卤代烷基中的取代基取代；或者可选地用亚甲基桥接；或者是一个具有O、NRa、S、S(=O)2等异原子的C4-C6饱和杂环；其中Ra是H、C1-C4烷基或CH3C(=O)；R5独立地选择自H或甲基；E是-C(=O)-、-S(=O)m-、-NR5S(=O)m-、-NR5C(=O)-、-OC(=O)-；R6是稳定的、可选择取代的、单环或双环的、碳环或杂环；m独立地为0、1或2；是猫hepsin K的抑制剂，并且在骨质疏松症的治疗或预防中有用。